For physician-owned, multispecialty and hospital joint venture surgery centers, where one unmatched authorization or one unsigned operative note can hold a four-figure facility fee for a quarter.
Get a free revenue cycle assessmentASC revenue cycle management is the financial control of a surgery center case from the moment it is posted to the schedule until the account reaches zero, covering eligibility, prior authorization, case completion, coding, claims, denials and payer contracts. ASC billing is one stage inside it: producing and following the facility claim.
Most specialties bill an encounter. A surgery center bills a case, and the case is one packaged facility payment that either arrives whole or does not arrive. Under 42 CFR 416.164 that payment absorbs nursing and technician services, the room, equipment, dressings, splints and casts, non pass-through supplies, drugs and implanted devices, and the materials and supervision of anesthesia administration. The surgeon, the anesthesia provider and the pathologist bill separately; the claim-side mechanics sit on our ASC billing services page. Packaging is what makes this unforgiving: there is no partial credit for the parts of a case documented correctly.
A clinic that loses a charge loses a charge. A center that cannot close a case loses the room, the staff, the implant and the anesthesia coordination with it, and that cost was already spent. Which is why days not final billed matters more here than days in AR.
Under 42 CFR 416.173 CMS republishes the covered procedures, the covered ancillary services and the rates annually, with addenda refreshed quarterly. For CY2026 the criteria themselves changed: five general exclusion criteria came out of 42 CFR 416.166 and became physician considerations for patient safety. A center whose contracts were written against the pre-2026 list is now booking cases it is not paid properly for. Volume then multiplies one error: an eye center running 30 cataract cases a day repeats its modifier template 30 times before anyone reads a remittance.
Any three together mean the revenue cycle, not the payer, is the problem.
Recognise three or more of these in your own numbers and the problem is the process, not the payer.
Get a free assessmentSurgery centers divide by who owns the contracts and who carries the AR, not by size. That decides where the revenue cycle breaks.
Ophthalmology, gastroenterology, orthopedic, pain and ENT centers. Narrow code set, dense schedule, concentration risk: one modifier habit, one payer, one rate line.
Four to eight service lines sharing two or three rooms, each with its own documentation path and payer rules. Charge capture, not coding, is the failure point. Centers wanting surgeon and anesthesia claims alongside the facility claim use our full-service medical billing team.
The hospital contributes contracts written for its outpatient department, and the center inherits terms never modeled against ASC economics.
Central contracting with local case management, where the question is whether center-level AR reaches people who can act on it. At a new center, contracts and enrollments are still being built while cases are performed, so first-year held revenue is a credentialing problem.
Part of the schedule is billed outside a contract, which changes estimates, patient balances and appeals for those cases.
The seven steps, with the point at which each fails in a surgery center.
The case is booked with a procedure, surgeon, date and room. Failure: the booked code and the planned code diverge once the surgeon finalises it.
Coverage, deductible position, coordination of benefits and the facility benefit are confirmed. Failure: checked at booking, never re-run.
Approval is obtained for the specific procedure, site and date. Failure: the case moves and the approval does not, the commonest reason a case is performed and never paid.
Operative note, anesthesia record, implant log and supply sheet become one billable case. Failure: the case waits unbilled while three of four documents exist.
Coders rank multiple procedures, apply payment modifiers and check the practitioner NCCI edits. Failure: ranking is wrong, so the 50% reduction under 42 CFR 416.171 lands on the higher paying line.
Medicare ASC facility claims go out on the professional format with place of service 24, not an institutional claim. Failure: a vendor builds them like hospital claims.
Underpayments identified, denials worked by root cause, appeals tracked. Failure: a short payment is posted as final. Appeals filed by Luxen were overturned 68% of the time.
Competing pages describe leakage in prose. Nobody tabulates it. Each leak is organised by cause, with annual exposure modeled for a center running 3,200 cases a year at about $750 of net facility revenue per case. Aged balances go to our denials and AR recovery team.
| Leak point | Codes or rule | What goes wrong | Annual dollars at risk | Luxen audit finding |
|---|---|---|---|---|
| Authorization does not match | Payer policy, site and date specific | The case moves and the approval does not | $264,000 | No match on 11% of ASC cases requiring prior authorization (Luxen claim audit) |
| Case never closes | Operative note, anesthesia record, implant log | One document is missing, so the case waits unbilled | $98,000 in cash timing | Median 6.8 days not final billed, slowest quartile 14 or more (Luxen billing reviews) |
| Multiple procedure ranking | 42 CFR 416.171, as on 29881 knee cases | The reduction falls on the higher paying line | $72,000 | Ranking errors underpaid 7% of multi-procedure sessions (Luxen audit) |
| Discontinued case reversed | Modifiers 73 and 74 | Stopped after induction, billed as before | $41,000 | The top three denial reasons accounted for 58% of denied dollars (Luxen billing reviews) |
| Underpayment posted as final | Contracted percentage of Medicare | Posted without comparison to contract | $168,000 | 9% of paid commercial facility claims came in under contract (Luxen audit) |
| Screening case that converts | Screening G0105 and G0121, diagnostic 45378 and family | Conversion is not flagged | $36,000 | Conversion flagged after the claim had gone out on 6% of endoscopy cases (Luxen claim audit) |
| Aged AR abandoned | Timely filing windows | Claims past 90 days stop being worked | $118,000 | The median practice had $118,000 in AR older than 120 days (Luxen client data) |
We will tell you which of these leaks is open in your practice, free, in 30 minutes.
Book the reviewSix competing pages name key performance indicators. None publishes a target. The Typical column is federal data only; where no federal file publishes a figure the cell says so. Target is Luxen client data. The CERT FY2025 report put the Medicare Part B improper payment rate at 8.4%, or $9.6 billion, and ASCs are not broken out in it.
| Metric | Definition | Typical | Target |
|---|---|---|---|
| Days in AR | AR over average daily charges | No federal file publishes AR ageing | 30 days or fewer |
| Net collection rate | Payments over charges net of contractuals | Not published federally | 97% or better |
| Clean claim rate | Accepted on first submission, no correction | Not published federally | 97% or better |
| First-pass denial rate | Denied on first adjudication | 19% of in-network claims denied by HealthCare.gov issuers on 2024 claims, ranging 3% to 36%, per the CMS Transparency in Coverage PUF for plan year 2026 | 6% or lower |
| Cost to collect | Revenue cycle cost over collections | Not published federally | 3% to 6% of collections |
| Days not final billed | Completed cases waiting on documentation | Not published federally | 2 days or fewer |
Typical values come from the named federal source in the table intro. Target values come from Luxen client data.
Authorization is where a surgery center loses whole cases rather than line items, because an ASC approval is specific in three dimensions: procedure, site of service and date. Change one and a payer can treat the service as unauthorised, even though it approved the same operation weeks earlier.
Centers move cases constantly, and each move opens a gap between the approval on file and the case performed. The authorization on file named a date, site or procedure code that did not match the case performed on 11% of ASC cases requiring prior authorization, across 3,900 ASC facility claims (Luxen claim audit). We bind approvals to the performed date and re-verify before the case, not after the denial.
Eligibility confirms coverage exists. Verification of benefits confirms the facility benefit, deductible position, coordination of benefits and whether the plan treats this site as in network. Eligibility was verified once at scheduling and not re-checked before the date of service at 14 of 23 surgery centers reviewed (Luxen billing reviews), so a plan change between booking and surgery is found on a remittance.
Medicare has no blanket ASC prior authorization requirement, which is why centers assume there is none. The exception is targeted: a CMS demonstration covers a named set of ASC services in some states, and a claim that bypasses it lands in prepayment medical review instead. Centers in Florida, Texas and New York sit inside that footprint. Our eligibility and prior authorization team files the requests and tracks each decision to the case.
Commercial plans apply medical policy to elective surgery: conservative care duration, imaging findings, documented failure of non-surgical treatment. When a plan declines, the recoverable path is a peer to peer conversation inside the appeal window, not a resubmission. Concurrent review matters where recovery is extended and the plan reassesses while the patient is on site. Appeals filed by Luxen were overturned 68% of the time, with a median appeal turnaround of 34 days from filing to payer decision (Luxen client data).
The signature revenue mechanic of a surgery center is the gap between what a case costs to perform and what the packaged facility fee pays for it. Other specialties manage charges. A center manages margin per slot, and the revenue cycle either protects it or gives it away.
Under 42 CFR 416.164 the payment covers the room, nursing and technician services, equipment, dressings, splints and casts, drugs and supplies without separate payment status, implanted devices not on pass-through status, and the materials and supervision of anesthesia administration. Separately payable items are narrow: brachytherapy sources, certain pass-through implantable items, corneal tissue acquisition, certain separately paid drugs and radiology, and certain non-opioid pain management items.
A procedure whose device offset exceeds 30% of procedure cost is device-intensive, and the device portion dominates payment. When the device arrives free or with a credit the claim must say so: a device furnished without cost or with full credit reduces payment by the entire device offset, and a partial credit of 50% or more reduces it by half that amount, under 42 CFR 416.179. Coinsurance recalculates on the reduced amount, both modifiers on one line is not permitted, and a pass-through device takes neither.
On a multiple procedure case Medicare pays 100% of the highest rate and 50% of the others under 42 CFR 416.171. Ranking is arithmetic, not judgement, and it runs against the current rate file. Multiple procedure ranking errors underpaid 7% of multi-procedure ASC sessions, across 3,900 ASC facility claims (Luxen claim audit). A discontinued case under modifier 73 and a reduced-services case under modifier 52 are both exempt from the further reduction, which is where expected payment is most often mis-modeled.
For procedures CMS designates as commonly performed in physicians' offices, the ASC rate is the lesser of the standard ASC amount or the non-facility practice expense amount under the physician fee schedule. Booking those into a room without checking the cap fills a slot at a loss. Our certified medical coders check every case before submission.
Medicare sets the reference price. Commercial contracts set the margin, and almost every ASC contract is a percentage of the Medicare ASC rate for a defined list of procedures. When the list changes, the contract does not.
The CY2026 final rule added 289 procedures to the covered procedures list under revised eligibility criteria and a further 271 codes that came off the inpatient only list, and began a three-year phase-out of that list with 285 mostly musculoskeletal procedures. Total ASC payments were projected at roughly $9.2 billion for the year, about $450 million above CY2025, on a 2.6% update. A joint or spine case that is newly payable in a center may still be carved out, silent or priced at a stale rate in a contract drafted two years ago. The CY2027 proposed rule would remove 638 more services from the inpatient only list. Separately, a center that misses ASC Quality Reporting deadlines loses 2.0 percentage points of its annual update under 42 CFR 416.172, applied to every Medicare case for the year.
A short payment looks identical to a correct one on a remittance unless something compares it to the contracted rate. Commercial ASC claims paid below the contracted rate on 9% of paid facility claims, across 3,900 ASC facility claims (Luxen claim audit). We load contract terms into the rate table, compare every commercial remittance against them and file the variance as a project rather than one claim at a time.
Bring case-level cost data, not a rate request. The defensible arguments are implant cost inflation on device-intensive cases, the site-of-service saving the plan realises against its hospital outpatient rate, and volume the center can move. Carve-outs for implants above a stated invoice threshold are easier to win than a percentage increase. Rates vary by state and payer mix; see our medical billing company comparison.
Days not final billed is the number to read before days in AR, because an unbilled case is not in AR at all. It is invisible in every report that starts at the claim, which is why it grows.
A billable case needs four artifacts to exist and agree: operative note, anesthesia record, implant log and supply sheet. They come from four people, in as many as three systems, on different timelines. Surgery centers reviewed carried a median 6.8 days not final billed, and the slowest quartile carried 14 days or more, across 23 surgery centers (Luxen billing reviews). The pattern is rarely missing documentation. Nobody is accountable for the case being complete, and the gap is widest where the operating room and billing report to different people.
42% of practice managers said nobody owns denial follow-up full time, and practice managers estimated 11 staff hours a week on insurance calls and portal checks (Luxen Practice Manager Survey 2026). In a center that unowned time sits between the operating room and billing, the most expensive place for it to sit, because nothing downstream can start until the case closes.
One queue, one owner, one daily review, and an ageing report for unbilled cases that looks exactly like the one for unpaid claims. Cases are chased at day one, not day seven. Practices that reviewed AR ageing monthly carried 12 fewer days in AR (Luxen billing reviews), and the same discipline applied before the claim compresses the front of the cycle further. Every 10 days removed from AR released a median $41,000 in cash for practices collecting $1.5 million to $3 million a year (Luxen billing reviews), and days not final billed sits in front of that number.
Dataset: 3,900 ASC facility claims from the Luxen claim audit and 23 surgery centers from the Luxen billing reviews, January 2025 to June 2026. We counted whether the authorization matched the case performed, how long a completed case waited to be billed, how procedures were ranked, and whether commercial payments matched contract.
The first two have no equivalent elsewhere: no published source quantifies authorization drift after a reschedule, or puts a number on days not final billed in a surgery center.
A four-room multispecialty center in the Southeast, roughly 3,100 cases a year across orthopedics, pain and GI, March 2025 to February 2026.
| Measure | Before | After 12 months |
|---|---|---|
| Days in AR | 58 | 31 |
| First-pass denial rate | 15.4% | 5.2% |
| Days not final billed | 9.1 | 1.8 |
| AR over 120 days | $391,000 | $74,000 |
$214,000 of that reduction was cash recovered, not written off, most of it from authorization and ranking denials closed without appeal. The Chief Financial Officer credited two moves: binding every approval to the performed date, and giving one person the unbilled case queue. Luxen client data.
ASC data only: 3,900 ASC facility claims in the Luxen claim audit, 23 surgery centers in the Luxen billing reviews, January 2025 to June 2026.
Rescheduled cases were still tied to the original authorization date, creating avoidable denials after the procedure. Luxen linked approvals to the performed date and reduced authorization-related ASC denials from 16% to 4%.
Facility Administrator, orthopedic ASC
Our days-not-final-billed total kept growing because no one owned the missing operative notes, supply records, and coding questions. Luxen created one accountable queue and reduced unbilled facility charges from $486,000 to $79,000.
Chief Financial Officer, multispecialty ambulatory surgery center
Worked for the same center: $2.4 million collected a year, roughly 3,200 cases, net collection rate 91.4% before the change.
| Step | Calculation | Amount |
|---|---|---|
| Net collectable revenue | $2,400,000 divided by 0.914 | $2,625,821 |
| Collections at 97.8% net collection rate | $2,625,821 multiplied by 0.978 | $2,568,053 |
| Annual collections gained | $2,568,053 minus $2,400,000 | $168,053 |
| Luxen fee at 4.5% of collections | $2,568,053 multiplied by 0.045 | $115,562 |
| Net annual gain against the fee | $168,053 minus $115,562 | $52,491 |
| Cash released by 22 fewer days in AR | 2.2 multiplied by $41,000 | $90,200 |
The basis: net collection rate rose from 91.4% to 97.8% over the first six months across 38 client practices (Luxen client data); the fee is the band midpoint; the AR line uses 22 days removed. Against the in-house total, that is $187,600 of internal cost versus $115,562 of fee.
Want this arithmetic run on your own collections and denial rate?
Run my numbersLuxen charges 3% to 6% of collections. No setup fee, no exit fee, month to month with 30 days notice.
Eligibility and benefits verification, authorization and appeal work, coding, claim production and scrubbing, submission through your clearinghouse, payment posting, underpayment identification, denial work by root cause, AR follow-up and monthly reporting. Statements run through our patient billing team.
No competing page compares the two costs, which is the decision an administrator is making. Below, a center collecting $2.4 million a year, on fully loaded staffing not base salary. Rates vary by market; see our state-by-state comparison.
| Line item | In-house | Luxen |
|---|---|---|
| Certified ASC facility coder, 1.0 FTE loaded | $78,000 | Included |
| AR and denials specialist, 1.0 FTE loaded | $62,000 | Included |
| Eligibility and authorization coordinator, 0.5 FTE | $27,000 | Included |
| Billing software and clearinghouse | $9,600 | Your systems, no migration |
| Denial rework and temporary cover | $11,000 | Included |
| Annual total | $187,600 | $77,000 to $154,000 at 3% to 6% |
A single-specialty center with a narrow code set, one or two dominant payers and a long-tenured coder is often better off keeping the work, provided a second person can cover. 34% of practice managers replaced a biller in the past two years (Luxen Practice Manager Survey 2026).
The question people type is which firms are largest. Size does not predict whether a vendor can rank a multiple procedure case correctly. Score each candidate out of 20, four points per criterion, and require a worked example.
| Criterion | What a four-point answer looks like |
|---|---|
| Facility claim competence | Names the claim format and place of service for Medicare ASC claims, and explains ranking |
| Front-end ownership | Owns matching authorizations to the performed date, not just claim submission |
| Denial reporting | A live report by payer, reason and dollars, with a tracked overturn rate, before you sign |
| Contract auditing | Compares every commercial remittance against a loaded rate table monthly |
| Commercial terms | States the fee basis in writing, including implant and drug lines, month to month |
A vendor that cannot produce a denial report in the first meeting will not produce one later. 63% could not name their top three denial reasons (Luxen Practice Manager Survey 2026).
Every center already has someone doing the work, so the question is what a change costs and how fast it repays.
A signed BAA, then access to the systems you run, then contract terms and rate tables loaded, then the oldest AR worked while current cases keep flowing. No migration, no gap in submission. Expect roughly two weeks from a signed BAA to claims being worked, and first recovered payments about three weeks in. Legacy AR is worked in parallel: we recovered 61% of the dollar value of claims aged 90 to 180 days that practices had stopped working, and claims aged past 180 days were recovered at 23% of dollar value (Luxen client data).
Surgery centers run case management, costing and billing in ASC-native systems. We work inside whatever you run, under a signed BAA, no migration.
Automate in this order, because each step makes the next worth more. First, eligibility re-verification tied to the date of service, not the booking date. Second, an unbilled case queue that ages like an AR report. Third, a rate table comparing every remittance against contract. Fourth, denial routing by root cause. Predictive scoring last, since it needs clean history. 38% had changed EHR or practice management system in the past five years, and of those, 71% said collections dipped for at least six months after the switch (Luxen Practice Manager Survey 2026).
Scheduling and case posting, eligibility and benefits verification, prior authorization and medical necessity, case completion and charge capture, coding and claim scrubbing, submission and adjudication, then posting, denials, appeals and AR. The stage most often skipped is the fourth, because an unbilled case never appears in an AR report.
There is no ranking worth using, because size does not predict competence on facility claims. Score candidates on five criteria: facility claim competence, authorization ownership, live denial reporting by payer and dollars, contract auditing against a loaded rate table, and terms in writing. Commercial ASC claims paid below the contracted rate on 9% of paid facility claims in our audit.
Medicare pays a packaged facility fee for procedures on the ASC covered procedures list, published annually under 42 CFR 416.173 and refreshed quarterly. The payment absorbs the room, staff, equipment, supplies and non pass-through implanted devices under 42 CFR 416.164. On multiple procedure cases, 42 CFR 416.171 pays 100% of the highest rate and 50% of the rest.
Luxen charges 3% to 6% of collections, with no setup or exit fee and month to month terms. For a center collecting $2.4 million a year that is roughly $77,000 to $154,000, against a modeled fully loaded in-house cost of $187,600. Case volume, implant workload and payer mix decide where in the band a center lands.
Roughly two weeks from a signed BAA to claims being worked, and first recovered payments about three weeks in. Across 38 client practices, median days in AR dropped from 54 to 33 within 120 days and net collection rate rose from 91.4% to 97.8% over the first six months (Luxen client data).
Billing starts at the claim. Revenue cycle management starts when the case is posted to the schedule and ends when the account reaches zero, so it owns eligibility, authorization matching, case completion, contract auditing and appeals as well as the claim. A center with excellent billing and no front end still loses whole cases to authorizations that no longer describe the procedure performed.
A free 30 minute review of your AR ageing and denial reasons. We tell you what is recoverable and what it would take. No deck, no commitment, no fee.
Book a free revenue cycle assessment